Literature DB >> 7737015

Neuromuscular dysfunction after surgical treatment of oral cancer.

A M Seppäläinen1, A L Söderholm, C Lindqvist.   

Abstract

Surgical treatment of oral cancer usually includes radical dissection of the neck, in which the sternocleidomastoid muscle is sacrificed. In modified neck dissection the accessory nerve is spared, but may be severed by e.g. manipulation. The facial nerve may also be severed by traction or distension. We have done an electromyographic study of 35 patients, 20 men and 15 women, aged from 21 to 92 yrs, 6 to 176 months after oral cancer operation. EMG findings of the upper trapezius muscle were normal in only six of 32 patients who had had a radical or upper neck dissection, although the accessory nerve had been identified and spared during surgery. The surgeons' evaluation of the risk to the facial nerve was in good correlation to EMG findings, both the orbicularis oris and the mentalis muscle were better preserved, if the risk was considered minor. The loss of motor units in voluntary contraction and the nerve latencies to the muscles were in good correlation to many factors from the spectral analysis of the EMG, e.g. to the root mean square (RMS), to the mean rectified value (MRV), to the mean amplitude and to the number of turns. The accessory nerve is easily damaged, and the injury is often not noted during neck dissection. Significant problems may also arise with lesions of the facial nerve. Quantitative EMG analysis may add to sensitivity of the postoperative EMG studies.

Entities:  

Mesh:

Year:  1995        PMID: 7737015

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  2 in total

1.  Safety of extracapsular dissection in benign superficial parotid lesions.

Authors:  F Riffat; A K Mahrous; M A Buchanan; B M Fish; P Jani
Journal:  J Maxillofac Oral Surg       Date:  2012-04-04

2.  Anatomic variations of the marginal mandibular nerve.

Authors:  P G Balagopal; Nebu Abraham George; P Sebastian
Journal:  Indian J Surg Oncol       Date:  2012-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.